Further studies to unravel the underlying mechanisms for the lack of viral control by IFN-γ during persistent infection and the roles of B cells in viral control will have significant implications when developing immunotherapeutic strategies for chronic hepatitis B. The gene discussed is IFNG; the disease is chronic hepatitis B virus infection.